Results 301 to 310 of about 100,070 (311)

Childhood Langerhans cell histiocytosis: a disease with many faces

World Journal of Pediatrics, 2019
A. Leung, J. Lam, K. Leong
semanticscholar   +1 more source

Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim–Chester Disease, Destombes–Rosai–Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders

Current Oncology Reports, 2019
M. Papo, F. Cohen-Aubart, L. Trefond, A. Bauvois, Z. Amoura, J. Emile, J. Haroche   +6 more
semanticscholar   +1 more source

The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease.

Mayo Clinic proceedings, 2019
G. Goyal, J. Young, Matthew J. Koster, W. Tobin, R. Vassallo, Jay H. Ryu, Caroline J. Davidge-Pitts, Maria D. Hurtado, A. Ravindran, J. C. Sartori Valinotti, N. Bennani, M. Shah, K. Rech, Ronald S. Go   +13 more
semanticscholar   +1 more source

Langerhans Cell Histiocytosis

The Journal of Emergency Medicine, 2019
Mike Kaiserian, Gal Altberg, Joshua Greenstein, Barry Hahn   +3 more
openaire   +3 more sources

Langerhans cell histiocytosis

Medicina Clínica (English Edition), 2017
Cristina Martínez Faci, Sara Laliena Aznar, Laura Murillo Sanjuan, Carmen Rodríguez-Vigil Iturrate   +3 more
openaire   +3 more sources

Langerhans cell histiocytosis in children: History, classification, pathobiology, clinical manifestations, and prognosis.

Journal of American Academy of Dermatology, 2018
J. Krooks, M. Minkov, A. Weatherall
semanticscholar   +1 more source

Langerhans Cell Histiocytosis

Dermatology, 1994
openaire   +3 more sources

The coming of age of Langerhans cell histiocytosis

Nature Immunology, 2019
C. Allen, P. Beverley, M. Collin, E. Diamond, R. Egeler, F. Ginhoux, C. Glass, M. Minkov, B. Rollins, A. V. van Halteren   +9 more
semanticscholar   +1 more source

Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study

International journal of hematology, 2018
A. Morimoto, Y. Shioda, T. Imamura, K. Kudo, T. Kitoh, H. Kawaguchi, H. Goto, Y. Kosaka, Y. Tsunematsu, S. Imashuku   +9 more
semanticscholar   +1 more source

Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study

International journal of hematology, 2016
A. Morimoto, Y. Shioda, T. Imamura, K. Kudo, H. Kawaguchi, K. Sakashita, M. Yasui, Yuhki Koga, R. Kobayashi, E. Ishii, J. Fujimoto, K. Horibe, F. Bessho, Y. Tsunematsu, S. Imashuku   +14 more
semanticscholar   +1 more source